Inventor · disambiguated record
Mathias Gehrmann
Also filed as: GEHRMANN MATHIAS
9 granted patents·20 pending applications·46 citations·filing 1997–2024
84Inventor score
Files withMYRIAD INT GMBH6GEHRMANN MATHIAS5SIEMENS HEALTHCARE DIAGNOSTICS4SIVIDON DIAGNOSTICS GMBH3BAYER AG2
Top patents by PatentIndex Score
29 records- 0180US2024229150A1Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2024·Application pending·0 cites
- 0279US7060495B2Fusion proteins for prodrug activationBEHRINGWERKE AG·Filed 1997·Granted Jun 13, 2006·30 cites·23 claims
- 0375US7668661B2Liver disease-related methods and systemsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2004·Granted Feb 23, 2010·3 cites·19 claims
- 0469US11913078B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 0568US2022307090A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2022·Application pending·0 cites
- 0667US7273727B2Fusion proteins for prodrug activationBEHRINWERKE AG·Filed 2005·Granted Sep 25, 2007·1 cites·14 claims
- 0765US10851427B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Dec 1, 2020·0 cites·41 claims
- 0863US7141380B2Assessment of liver fibrosis scoring with serum marker algorithmsVOLKER MICHAEL·Filed 2001·Granted Nov 28, 2006·10 cites·19 claims
- 0963US2019144949A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2019·Application pending·0 cites
- 1061US2024124572A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1161US2024317847A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1260US10577661B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2016·Granted Mar 3, 2020·0 cites·19 claims
- 1358US2014228241A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrentbreast cancerGEHRMANN MATHIAS·Filed 2012·Application pending·0 cites
- 1457US2013065786A1Method for breast cancer recurrence prediction under endocrine treatmentDARTMANN MAREIKE·Filed 2011·Application pending·0 cites
- 1557US2011166838A1Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancerSividon Diagnostics·Filed 2009·Application pending·0 cites
- 1657US2012053842A9Molecular markers for cancer prognosisGEHRMANN MATHIAS·Filed 2009·Application pending·0 cites
- 1752US2017081728A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2016·Application pending·0 cites
- 1852US2009311700A1Methods for Breast Cancer PrognosisSIEMENS HEALTHCARE DIAGNOSITCS·Filed 2007·Application pending·0 cites
- 1950US2011143946A1Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agentSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2008·Application pending·0 cites
- 2050US2009239223A1Prediction of Breast Cancer Response to Taxane-Based ChemotherapySIEMENS HEALTHCARE DIAGNOSTICS·Filed 2007·Application pending·0 cites
- 2148US10301685B2Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2017·Granted May 28, 2019·0 cites·10 claims
- 2247US2015376714A1Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2014·Application pending·0 cites
- 2347US2009069196A1Prediction of Breast Cancer Response to ChemotherapyGEHRMANN MATHIAS·Filed 2007·Application pending·0 cites
- 2447US2012034629A1Prediction of non-fatal and fatal atherothrombotic eventsGEHRMANN MATHIAS·Filed 2007·Application pending·0 cites
- 2546US2009222387A1Diagnosis, Prognosis and Prediction of Recurrence of Breat CancerGEHRMANN MATHIAS·Filed 2006·Application pending·0 cites
- 2645US2007166757A1Relaxin as an independent risk factor predicting mortalityBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 2744US2005064421A1Profiling of the immune gene repertoireBAYER HEALTHCARE AG·Filed 2002·Application pending·0 cites
- 2841US2009130678A1Methods and Kits for Breast Cancer PrognosisSIEMENS MEDICAL SOLUTIONS DIAG·Filed 2006·Application pending·0 cites
- 2938US7541149B1Monoclonal antibody and assay for detecting PIIINPSIEMENS HEALTHCARE DIAGNOSTICS·Filed 1999·Granted Jun 2, 2009·2 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →